Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk

Kearney, K, Tomlinson, D orcid.org/0000-0003-4134-7484, Smith, K orcid.org/0000-0001-5695-7117 et al. (1 more author) (2017) Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovascular Diabetology, 16. 34. ISSN 1475-2840

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Fibrinolysis; Diabetes; Fibrinogen
Dates:
  • Published: 9 March 2017
  • Accepted: 27 February 2017
  • Published (online): 9 March 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Genetics, Health and Therapeutics (LIGHT) > Academic Unit of Cardiovascular Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Mar 2017 13:24
Last Modified: 05 Oct 2017 16:18
Published Version: https://doi.org/10.1186/s12933-017-0515-9
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s12933-017-0515-9

Share / Export

Statistics